Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2005

Sutthent Ruengpung, Arworn Daungnapa, Kaoriangudom Surapol, Chokphaibulkit Kulkanya, Chaisilwatana Pongsakdi, Wirachsilp Piyanot, Thiamchai Vipa, Sirapraphasiri Thaweesarp, Tanprasertsuk Sombat

Abstract excerpt

BACKGROUND: The Ministry of Public Health (Thailand), MoPH, has had a program called National Access to Antiretroviral Program for People who have AIDS (PHA) or "NAPHA", to offer free antiretroviral drugs (ARV), which are locally produced in Thailand, to any HIV-1 infected patients with CD4<200 since 2002. This program may increase usage of ARV therapy and the emergence of HIV-1 drug resistance. OBJECTIVES: To...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Genes, pol

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Health Surveys

Share to HIV Reverse Transcriptase

Share to Nevirapine

Share to Reverse Transcriptase Inhibitors

Share to Thailand

Share to Thymidine

Source

Identifiers

PMID: 16286051
DOI: 10.1016/j.jcv.2005.02.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.PMID 16286051Read ↗

Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance in treated HIV-1 infected patients: under the initiative of access to the NNRTI-based regimen in Thailand.Semantic proximity Read ↗

SURVEILLANCE OF HIV-1 DRUG-RESISTANCE MUTATIONS IN THAILAND FROM 1999 TO 2014.Semantic proximity Read ↗

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.Semantic proximity Read ↗

Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.Semantic proximity Read ↗

Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010.Semantic proximity Read ↗

Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand.Semantic proximity Read ↗

Prevalence of HIV-1 polymerase gene mutations in pre-treated patients in Thailand.Semantic proximity Read ↗

Transmitted HIV drug resistance at the Thai Red Cross anonymous clinic in Bangkok: results from three consecutive years of annual surveillance.Semantic proximity Read ↗

High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men.Semantic proximity Read ↗

Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.Semantic proximity Read ↗

HIV drug resistance transmission threshold survey in Bangkok, Thailand.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.